254 related articles for article (PubMed ID: 29630333)
1. Different Positron Emission Tomography Tau Tracers Bind to Multiple Binding Sites on the Tau Fibril: Insight from Computational Modeling.
Murugan NA; Nordberg A; Ågren H
ACS Chem Neurosci; 2018 Jul; 9(7):1757-1767. PubMed ID: 29630333
[TBL] [Abstract][Full Text] [Related]
2. Cryptic Sites in Tau Fibrils Explain the Preferential Binding of the AV-1451 PET Tracer toward Alzheimer's Tauopathy.
Murugan NA; Nordberg A; Ågren H
ACS Chem Neurosci; 2021 Jul; 12(13):2437-2447. PubMed ID: 34152739
[TBL] [Abstract][Full Text] [Related]
3. Cross-interaction of tau PET tracers with monoamine oxidase B: evidence from in silico modelling and in vivo imaging.
Murugan NA; Chiotis K; Rodriguez-Vieitez E; Lemoine L; Ågren H; Nordberg A
Eur J Nucl Med Mol Imaging; 2019 Jun; 46(6):1369-1382. PubMed ID: 30919054
[TBL] [Abstract][Full Text] [Related]
4. Computational Insight into the Binding Profile of the Second-Generation PET Tracer PI2620 with Tau Fibrils.
Kuang G; Murugan NA; Zhou Y; Nordberg A; Ågren H
ACS Chem Neurosci; 2020 Mar; 11(6):900-908. PubMed ID: 32069017
[TBL] [Abstract][Full Text] [Related]
5. Pick's Tau Fibril Shows Multiple Distinct PET Probe Binding Sites: Insights from Computational Modelling.
Mishra SK; Yamaguchi Y; Higuchi M; Sahara N
Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33396273
[TBL] [Abstract][Full Text] [Related]
6. Dissecting the Binding Profile of PET Tracers to Corticobasal Degeneration Tau Fibrils.
Zhou Y; Li J; Nordberg A; Ågren H
ACS Chem Neurosci; 2021 Sep; 12(18):3487-3496. PubMed ID: 34464084
[TBL] [Abstract][Full Text] [Related]
7. Comparative binding properties of the tau PET tracers THK5117, THK5351, PBB3, and T807 in postmortem Alzheimer brains.
Lemoine L; Gillberg PG; Svedberg M; Stepanov V; Jia Z; Huang J; Nag S; Tian H; Ghetti B; Okamura N; Higuchi M; Halldin C; Nordberg A
Alzheimers Res Ther; 2017 Dec; 9(1):96. PubMed ID: 29229003
[TBL] [Abstract][Full Text] [Related]
8. Investigation of the Binding Profiles of AZD2184 and Thioflavin T with Amyloid-β(1-42) Fibril by Molecular Docking and Molecular Dynamics Methods.
Kuang G; Murugan NA; Tu Y; Nordberg A; Ågren H
J Phys Chem B; 2015 Sep; 119(35):11560-7. PubMed ID: 26266837
[TBL] [Abstract][Full Text] [Related]
9. Free Energy Profile for Penetration of Pittsburgh Compound-B into the Amyloid β Fibril.
Zou R; Kuang G; Ågren H; Nordberg A; Långström B; Tu Y
ACS Chem Neurosci; 2019 Mar; 10(3):1783-1790. PubMed ID: 30698013
[TBL] [Abstract][Full Text] [Related]
10. Effect of Alzheimer Familial Chromosomal Mutations on the Amyloid Fibril Interaction with Different PET Tracers: Insight from Molecular Modeling Studies.
Balamurugan K; Murugan NA; Långström B; Nordberg A; Ågren H
ACS Chem Neurosci; 2017 Dec; 8(12):2655-2666. PubMed ID: 28898051
[TBL] [Abstract][Full Text] [Related]
11. Dual tracer tau PET imaging reveals different molecular targets for
Chiotis K; Stenkrona P; Almkvist O; Stepanov V; Ferreira D; Arakawa R; Takano A; Westman E; Varrone A; Okamura N; Shimada H; Higuchi M; Halldin C; Nordberg A
Eur J Nucl Med Mol Imaging; 2018 Jul; 45(9):1605-1617. PubMed ID: 29752516
[TBL] [Abstract][Full Text] [Related]
12. The Sensitivity of Tau Tracers for the Discrimination of Alzheimer's Disease Patients and Healthy Controls by PET.
Mohammadi Z; Alizadeh H; Marton J; Cumming P
Biomolecules; 2023 Feb; 13(2):. PubMed ID: 36830659
[TBL] [Abstract][Full Text] [Related]
13. Molecular Mechanisms of Alzheimer's Biomarker FDDNP Binding to Aβ Amyloid Fibril.
Parikh ND; Klimov DK
J Phys Chem B; 2015 Sep; 119(35):11568-80. PubMed ID: 26237080
[TBL] [Abstract][Full Text] [Related]
14. Large inter- and intra-case variability of first generation tau PET ligand binding in neurodegenerative dementias.
Wren MC; Lashley T; Årstad E; Sander K
Acta Neuropathol Commun; 2018 May; 6(1):34. PubMed ID: 29716656
[TBL] [Abstract][Full Text] [Related]
15. Insight into the Binding of First- and Second-Generation PET Tracers to 4R and 3R/4R Tau Protofibrils.
Li J; Kumar A; Långström B; Nordberg A; Ågren H
ACS Chem Neurosci; 2023 Sep; 14(18):3528-3539. PubMed ID: 37639522
[TBL] [Abstract][Full Text] [Related]
16. Tau PET imaging in Alzheimer's disease.
Okamura N; Harada R; Furumoto S; Arai H; Yanai K; Kudo Y
Curr Neurol Neurosci Rep; 2014 Nov; 14(11):500. PubMed ID: 25239654
[TBL] [Abstract][Full Text] [Related]
17. Tau fibril with membrane lipids: Insight from computational modeling and simulations.
Barredo PA; Fernandez MJF; Ambe CE; Balanay MP
PLoS One; 2021; 16(10):e0258692. PubMed ID: 34653235
[TBL] [Abstract][Full Text] [Related]
18. Multistep Modeling Strategy To Improve the Binding Affinity Prediction of PET Tracers to Aβ
Balamurugan K; Murugan NA; Ågren H
ACS Chem Neurosci; 2016 Dec; 7(12):1698-1705. PubMed ID: 27626391
[TBL] [Abstract][Full Text] [Related]
19. Distinct binding of PET ligands PBB3 and AV-1451 to tau fibril strains in neurodegenerative tauopathies.
Ono M; Sahara N; Kumata K; Ji B; Ni R; Koga S; Dickson DW; Trojanowski JQ; Lee VM; Yoshida M; Hozumi I; Yoshiyama Y; van Swieten JC; Nordberg A; Suhara T; Zhang MR; Higuchi M
Brain; 2017 Mar; 140(3):764-780. PubMed ID: 28087578
[TBL] [Abstract][Full Text] [Related]
20. Tau PET imaging: present and future directions.
Saint-Aubert L; Lemoine L; Chiotis K; Leuzy A; Rodriguez-Vieitez E; Nordberg A
Mol Neurodegener; 2017 Feb; 12(1):19. PubMed ID: 28219440
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
